KIM-1 expression in kidney allograft biopsies: Improving the gold standard.
Long-term outcomes of kidney allografts have shown only marginal improvement over the last three decades, despite the remarkable improvement in acute rejection and one-year graft survival. Novel biomarkers of tubular injury may prevent irreversible damage to the tubulointerstitial compartment and improve allograft survival.
Abulezz
S
S
University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA. abulezzsamehr@uams.edu
D058186:Acute Kidney Injury / Q000175:diagnosis*; D000818:Animals; D015415:Biomarkers / Q000032:analysis; D006084:Graft Rejection / Q000175:diagnosis*; D006085:Graft Survival; D000072596:Hepatitis A Virus Cellular Receptor 1; D006801:Humans; D016030:Kidney Transplantation; D008562:Membrane Glycoproteins / Q000032:analysis*; D051381:Rats; D011991:Receptors, Virus / Q000032:analysis*
D015415:Biomarkers; C491143:HAVCR1 protein, human; D000072596:Hepatitis A Virus Cellular Receptor 1; D008562:Membrane Glycoproteins; D011991:Receptors, Virus